Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reactive arthritis: newer developments.

Diana Flores1, Javier Marquez, Mario Garza

  • 1Section of Rheumatology, Department of Medicine, Louisiana State University Health Sciences Center, 1542 Tulane Avenue, New Orleans, LA 70112-2822, USA.

Rheumatic Diseases Clinics of North America
|March 15, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case-control study of autonomic symptoms in the setting of Long COVID with tilt table testing.

PloS one·2025
Same author

Functional parameters of spermatozoa obtained by a new selection device.

FEBS open bio·2025
Same author

Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer.

NPJ precision oncology·2025
Same author

Loss of Glutaminase 1 in Small Sensory Neurons Prevents Nerve Injury Induced Mechanical Allodynia: Insights From Conditional Knockout Mice.

European journal of pain (London, England)·2025
Same author

PROX1 is an early driver of lineage plasticity in prostate cancer.

The Journal of clinical investigation·2025
Same author

Prognostic Factors in Pleural Mesothelioma Patients Receiving First-Line Chemotherapy: Establishing the PLECH Baseline Risk Score.

Oncology·2025

Reactive arthritis (ReA) is joint inflammation following infection in genetically susceptible individuals. Treatments include NSAIDs, sulfasalazine, steroids, and newer biologics for refractory cases.

Area of Science:

  • Rheumatology
  • Immunology
  • Infectious Diseases

Background:

  • Reactive arthritis (ReA) is a sterile inflammatory joint condition.
  • It occurs in genetically predisposed individuals post-infection.
  • Typically follows enteric or urogenital infections.

Purpose of the Study:

  • To summarize the understanding of Reactive Arthritis.
  • To review current and emerging treatment modalities.

Main Methods:

  • Literature review of Reactive Arthritis.
  • Analysis of therapeutic outcomes.

Main Results:

  • Conventional therapies (NSAIDs, sulfasalazine, steroids) are effective for most patients.
  • Refractory cases benefit from methotrexate and biologics like etanercept and infliximab.

Related Experiment Videos

  • Antibiotics show potential in acute urogenital-origin ReA.

    • Conclusions:

    • Reactive arthritis management involves a stepwise approach.
    • Biologics offer new hope for severe or refractory cases.
    • Further research is needed on antibiotic efficacy.